Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 519 pseudogene 3 (ZNF519P3) is annotated as a human pseudogene, meaning it resembles the sequence of a functional gene (in this case, ZNF519, which is a predicted DNA-binding transcription factor), but ZNF519P3 itself does not encode an active protein and is not known to have biological or clinical relevance[1][4]. No aliases, biological activities, molecular functions, disease roles, or clinical drugs are reported for ZNF519P3, and it should not be considered a therapeutic target. The name is derived from the parent gene family, which encodes a transcription factor, but ZNF519P3 is not believed to have any function beyond serving as a genomic remnant or possibly as a noncoding RNA sequence in research contexts. If you meant ZNF519 (without pseudogene annotation), refer to "Zinc finger protein 519 (ZNF519)", which is a predicted transcription factor but not a clinically validated drug target[7][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 519 pseudogene 3 (ZNF519P3).